Device Trial Radar · NCT05875987
Evaluation of the Quantra QStat System in Obstetric Patients
Last checked: Nov 20, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jun 1, 2023
Primary completion
Mar 31, 2024
Study completion May 10, 2024
Sponsor
- Lead sponsor
- HemoSonics LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 25, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Conditions
- Blood Loss Massive
- Post Operative Hemorrhage
Interventions
Quantra SystemDevice
Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of Quantra Clot Time to laboratory aPTT test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth
- Comparison of Quantra Fibrinogen Contribution to Clot Stiffness to laboratory coagulation fibrinogen test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth
- Comparison of Quantra Clot Time to ROTEM delta INTEM CT test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Duke University Hospital
Durham, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.